Drug
PF 08653944
PF 08653944: highest development phase Phase 1, developed by Pfizer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PF-08653944 NCT07845513 | Phase 1 | Overweight |
| PF-08653944 NCT07519135 | Phase 1 | Healthy |
Latest
No recent events.
Follow PF 08653944 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.